Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients. (PubMed, Kidney Int Rep) - Dec 18, 2023 - "This proof-of-concept study shows a potential positive risk-benefit profile for voclosporin in immunocompromised patients with SARS-CoV-2 infection. These results warrant further investigations on voclosporin to establish an equipoise between infection and maintenance immunosuppression."
Journal • Glomerulonephritis • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Novel Coronavirus Disease • Respiratory Diseases • Transplantation
|
|
Aiko P J de Vries; Cees van Kooten; Dirk Jan A R Moes; Eline J Arends; Eric C J Claas; Eric J Snijder; Leo G Visser; Mariet C W Feltkamp; Martijn van Hemert; Natacha S Ogando; Sandra van der Kooy; Soufian Meziyerh; Sylvia W A Kamerling; Ton J Rabelink; Y K Onno Teng
|